Alembic Pharmaceuticals intimates of USFDA inspection of facility at Panelav

Receives 3 observations under Form 483

Alembic Pharmaceuticals announced that the USFDA has conducted an inspection at Alembic Pharmaceuticals Formulation Facility located at Panelav from 12 March, 2018 to 20 March, 2018. This was a scheduled inspection and at the end of the inspection, the US FDA issued a Form 483 with 3 observations.

Powered by Capital Market - Live News